ITEM 8.01. OTHER EVENTS
On January 30, 2009, the Company received the $6.375 million payment from
Auxilium Pharmaceuticals, Inc. ("Auxilium") owed to the Company in connection
with its entry into the Amended and Restated Development and License Agreement
with Auxilium on December 11, 2008. Auxilium paid to the Company $6.375 million
of the $75 million upfront payment that it received from Pfizer, Inc. under the
Development, Commercialization and Supply Agreement, dated December 17, 2008
between Auxilium and Pfizer, Inc.
Add
BSTC.OB to Portfolio
Set Alert
Email to a
Friend